Developing Countries Clinical Trials Partnership / /
Continent
Africa / Asia / Americas / /
Country
Belarus / Bahrain / Estonia / Oman / Algeria / Tunisia / Iran / Latvia / Kuwait / South Africa / Swaziland / Sudan / Kazakhstan / Egypt / France / Russia / Uganda / United States / Soviet Union / Libyan Arab Jamahiriya / Moldova / Tanzania / Botswana / United Kingdom / China / Morocco / Lithuania / Ukraine / India / /
Currency
USD / /
Facility
Alan Guttmacher Institute / /
IndustryTerm
biotechnology firms / prevention services / prevention of HIV / health services / HIV prevention / care services / pharmaceutical / social services / reproductive health services / life skills services / prevention tools / difficulties raising venture capital / sexual networking / healthcare providers / /
MedicalCondition
Global AIDS Epidemic / cuts / generalized epidemics / HIV / epidemic / AIDS epidemic / HIV epidemic / infections / HIV infection / disease / epidemic prevalence / chronic disease / sexually transmitted infections / AIDS / HIV/AIDS / HIV/AIDS Epidemic / infection / /
General Assembly / Government of the United States / World Health Organization / Global Coalition on Women and AIDS / United Nations Development Fund for Women / Global Coalition on Women / United Nations Population Fund / United States Agency for International Development / Civil society / United Nations / IPPF / Alan Guttmacher Institute / Medical Research Council of the United Kingdom / UNAIDS / /
Position
Vulnerability Adviser / official national bodies / /
Product
nevirapine / /
Region
sub-Saharan Africa / Western Asia / East Africa / southern Sudan / Middle East / North Africa / eastern Asia / Southern Africa / Latin America / Central Asia / Caribbean / Eastern Europe / Asia Pacific / SouthEastern Asia / /
XIII. RELEVANCE OF POPULATION ASPECTS FOR THE ACHIEVEMENT OF MILLENNIUM DEVELOPMENT GOALS 6 AND 3: COMBATTING THE SPREAD OF HIV/AIDS Aurorita Mendoza Prevention and Vulnerability Adviser UNAIDS Geneva